{
    "2018-09-11": [
        [
            {
                "time": "2018-09-25",
                "original_text": "Pfizer Announces Results for JAVELIN Renal 101 Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "JAVELIN",
                        "Renal",
                        "Study",
                        "Results"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-13",
                "original_text": "Pfizer to Idle Plants in North Carolina With Hurricane Florence Approaching",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Idle",
                        "Plants",
                        "Hurricane",
                        "Florence"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-09-24",
                "original_text": "3 Small Biotech Stocks That Almost Doubled in Past Month",
                "features": {
                    "keywords": [
                        "Biotech",
                        "Stocks",
                        "Doubled",
                        "Past Month"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-26",
                "original_text": "Merck KGaA, Pfizer's immuno-drug shown to alleviate kidney cancer",
                "features": {
                    "keywords": [
                        "Merck",
                        "Pfizer",
                        "immuno-drug",
                        "kidney",
                        "cancer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-27",
                "original_text": "Merck, Pfizer Report Positive Top-line Results From Phase III JAVELIN 101 Study",
                "features": {
                    "keywords": [
                        "Merck",
                        "Pfizer",
                        "Positive",
                        "Top-line",
                        "Results",
                        "Phase III",
                        "JAVELIN",
                        "Study"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}